Related Experiment Video
Updated: May 19, 2026
An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells
Published on: May 21, 2019
A functional screen identifies specific microRNAs capable of inhibiting human melanoma cell viability
Jos B Poell1, Rick J van Haastert, Thijs de Gunst
1Hubrecht Institute, University Medical Center Utrecht, Cancer Genomics Center, Utrecht, The Netherlands.
Abstract:
Malignant melanoma is an aggressive form of skin cancer with poor prognosis. Despite improvements in awareness and prevention of this disease, its incidence is rapidly increasing. MicroRNAs (miRNAs) are a class of small RNA molecules that regulate cellular processes by repressing messenger RNAs (mRNAs) with partially complementary target sites. Several miRNAs have already been shown to attenuate cancer phenotypes, by limiting proliferation, invasiveness, tumor angiogenesis, and stemness. Here, we employed a genome-scale lentiviral human miRNA expression library to systematically survey which miRNAs are able to decrease A375 melanoma cell viability. We highlight the strongest inhibitors of melanoma cell proliferation, including the miR-15/16, miR-141/200a and miR-96/182 families of miRNAs and miR-203. Ectopic expression of these miRNAs resulted in long-term inhibition of melanoma cell expansion, both in vitro and in vivo. We show specifically miR-16, miR-497, miR-96 and miR-182 are efficient effectors when introduced as synthetic miRNAs in several melanoma cell lines. Our study provides a comprehensive interrogation of miRNAs that interfere with melanoma cell proliferation and viability, and offers a selection of miRNAs that are especially promising candidates for application in melanoma therapy.
Insights
MicroRNAs (miRNAs) can inhibit melanoma cell growth. This study identified specific miRNAs, like miR-16 and miR-96, that effectively reduce melanoma cell viability and proliferation, offering potential therapeutic strategies for this aggressive skin cancer.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Malignant melanoma is an aggressive skin cancer with increasing incidence and poor prognosis.
- MicroRNAs (miRNAs) are small RNA molecules that regulate gene expression and can suppress cancer phenotypes.
- Identifying specific miRNAs that inhibit melanoma cell growth is crucial for developing novel therapies.
Purpose of the Study:
- To systematically identify microRNAs (miRNAs) capable of reducing A375 melanoma cell viability.
- To evaluate the potential of specific miRNAs as therapeutic agents against melanoma.
- To investigate the long-term effects of miRNA expression on melanoma cell proliferation.
Main Methods:
- Utilized a genome-scale lentiviral human miRNA expression library to screen for melanoma cell viability inhibitors.
- Performed ectopic expression of candidate miRNAs in melanoma cell lines.
- Assessed the impact of miRNA expression on cell proliferation both in vitro and in vivo.
Main Results:
- Identified several potent miRNA inhibitors of melanoma cell proliferation, including miR-15/16, miR-141/200a, miR-96/182 families, and miR-203.
- Demonstrated that ectopic expression of these miRNAs leads to long-term inhibition of melanoma cell expansion.
- Confirmed miR-16, miR-497, miR-96, and miR-182 as effective synthetic miRNA candidates in multiple melanoma cell lines.
Conclusions:
- This study provides a comprehensive analysis of miRNAs that interfere with melanoma cell proliferation and viability.
- Specific miRNAs, including miR-16, miR-497, miR-96, and miR-182, show significant promise for melanoma therapy.
- These identified miRNAs represent promising candidates for future development in the treatment of malignant melanoma.
Related Concept Videos
01:22MicroRNAs
01:22MicroRNAs
01:22MicroRNAs